Enterprise Pharmacy Forward

Sign in Subscribe

Enterprise Pharmacy

Navigating pharmaceutical tariffs: Preparing for price pressures and supply chain disruptions

Navigating pharmaceutical tariffs: Preparing for price pressures and supply chain disruptions

Jamie Miller Tariffs on imported pharmaceuticals are likely to lead to increased drug prices and potential shortages, impacting patients, providers and healthcare systems. While tariffs aim to protect domestic industries, public health experts anticipate that the costs of tariffs on imported drugs will likely be passed on to consumers, potentially

Expanding clinical impact: Specialty MTDM’s role in collaborative, patient-centered care

Susanne Burns, Amanda Popko, Allyson Hess and Allison Cebulko Specialty MTDM continues to expand its clinical footprint through innovative partnerships and interdisciplinary care models that enhance patient access, optimize therapy and improve outcomes across a growing number of specialties. These initiatives demonstrate the critical role of pharmacists in advancing systemwide

Unlocking the power of pharmacogenomics: MyCode’s role in safer, smarter prescribing

Unlocking the power of pharmacogenomics: MyCode’s role in safer, smarter prescribing

Ryley Uber The Geisinger MyCode® Community Health Initiative has been underway for nearly 2 decades, positively influencing our understanding of how genomics affect health while enabling pathways for clinical confirmation of genomic results. Yet a key question remains: How can MyCode pharmacogenomic (PGx) data be used to improve medication outcomes

Balancing demand and evidence: MTDM’s oversight of GLP-1 prescribing

Susanne Burns, Amanda Popko and Allison Cebulko In response to the rising cost and growing demand for GLP-1 receptor agonists, Specialty MTDM, in collaboration with the Value & Strategy team, implemented a systemwide initiative designed to make sure prescribing practices remain clinically appropriate and financially sustainable. GLP-1 therapies,

Streamlining access: Centralized prior authorization management improves efficiency and patient care

Hank Aftewicz and Jessica Hodle A centralized prior authorization (PA) management process was implemented for electronic PA (ePA) requests originating from 38 of Geisinger’s primary care clinics. This initiative involved transitioning all ePA volume to the Centralized Clinical Pharmacy Services (CCPS) team, with the goal of developing a standardized

Medication reconciliation transformation: Enhancing safety across the care continuum

Brian Simpkins Geisinger has launched a multi-phase initiative to improve medication reconciliation processes across the system, with a focus on strengthening patient safety and care continuity from admission through discharge. The effort addresses longstanding challenges related to medication accuracy, workflow consistency and system integration. The initial phase targets transitions

Gene therapy administration: A collaborative model for complex care

Sarah Hale Geisinger continues to expand its capabilities in delivering advanced therapies. Among the most notable are gene therapies for pediatric patients, including onasemnogene abeparvovec-xioi (Zolgensma) for spinal muscular atrophy (SMA) and delandistrogene moxeparvovec-rokl (Elevidys) for Duchenne muscular dystrophy (DMD). These treatments represent some of the most complex